HYPERRAB
- Product NDC
- 13533-618
- 11-digit product format
- 135330618
- Labeler code
- 13533
- Product ID
- 13533-618_58aefdbd-27e0-46a7-905e-aefb089a92b2
- Type
- PLASMA DERIVATIVE
- Nonproprietary name
- RABIES IMMUNE GLOBULIN (HUMAN)
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR
- Labeler
- GRIFOLS USA, LLC
- Application
- BLA101144
- Marketing category
- BLA
- Marketing start
- 1996-08-14
- Substance
- HUMAN RABIES VIRUS IMMUNE GLOBULIN
- Active strength
- 150 [iU]/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- HYPERRAB
- Brand name suffix
- S/D
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| HUMAN RABIES VIRUS IMMUNE GLOBULIN | 150 [iU]/mL |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 13533-618-02 | HYPERRAB S/D | 1 in 1 CARTON | INJECTION | 1 | | 22 |
| 13533-618-10 | HYPERRAB S/D | 1 in 1 CARTON | INJECTION | 1 | | 22 |
| 13533-618-11 | HYPERRAB S/D | 10 mL in 1 VIAL | INJECTION | 10 | | 22 |
| 13533-618-20 | HYPERRAB S/D | 2 mL in 1 VIAL, GLASS | INJECTION | 2 | | 22 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 13533-618 | HYPERRAB S/D (RABIES IMMUNE GLOBULIN (HUMAN)) INJECTION [GRIFOLS USA, LLC] | 22 | Current NDC, Legacy NDC, 4 package rows | 20221110_6183eb49-fd6e-4ec2-b41f-8a8dcbd9d4f0.zip |
DailyMed RxNorm Mappings#
RxCUI, RxNorm string, TTY table| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|
| 1652834 | HyperRAB 150 UNT/ML in 10 ML Injection | PSN | 6183eb49-fd6e-4ec2-b41f-8a8dcbd9d4f0 | 22 |
| 1652830 | HyperRAB 150 UNT/ML in 2 ML Injection | PSN | 6183eb49-fd6e-4ec2-b41f-8a8dcbd9d4f0 | 22 |
| 1652833 | rabies immune globulin, human 150 UNT/ML in 10 ML Injection | PSN | 6183eb49-fd6e-4ec2-b41f-8a8dcbd9d4f0 | 22 |
| 1652827 | rabies immune globulin, human 150 UNT/ML in 2 ML Injection | PSN | 6183eb49-fd6e-4ec2-b41f-8a8dcbd9d4f0 | 22 |
| 1652834 | 10 ML rabies immune globulin, human 150 UNT/ML Injection [HyperRAB] | SBD | 6183eb49-fd6e-4ec2-b41f-8a8dcbd9d4f0 | 22 |
| 1652830 | 2 ML rabies immune globulin, human 150 UNT/ML Injection [HyperRAB] | SBD | 6183eb49-fd6e-4ec2-b41f-8a8dcbd9d4f0 | 22 |
| 1652833 | 10 ML rabies immune globulin, human 150 UNT/ML Injection | SCD | 6183eb49-fd6e-4ec2-b41f-8a8dcbd9d4f0 | 22 |
| 1652827 | 2 ML rabies immune globulin, human 150 UNT/ML Injection | SCD | 6183eb49-fd6e-4ec2-b41f-8a8dcbd9d4f0 | 22 |
| 1652834 | 10 ML HyperRAB 150 UNT/ML Injection | SY | 6183eb49-fd6e-4ec2-b41f-8a8dcbd9d4f0 | 22 |
| 1652830 | 2 ML HyperRAB 150 UNT/ML Injection | SY | 6183eb49-fd6e-4ec2-b41f-8a8dcbd9d4f0 | 22 |
| 1652830 | HyperRAB 150 UNT/ML in 2 ML Injection | SY | 6183eb49-fd6e-4ec2-b41f-8a8dcbd9d4f0 | 22 |
| 1652834 | HyperRAB 150 UNT/ML per 10 ML Injection | SY | 6183eb49-fd6e-4ec2-b41f-8a8dcbd9d4f0 | 22 |
| 1652833 | rabies immune globulin, human 150 UNT/ML per 10 ML Injection | SY | 6183eb49-fd6e-4ec2-b41f-8a8dcbd9d4f0 | 22 |
| 1652827 | rabies immune globulin, human 150 UNT/ML per 2 ML Injection | SY | 6183eb49-fd6e-4ec2-b41f-8a8dcbd9d4f0 | 22 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 13533-618-02 | 13533061802 | 1 VIAL, GLASS in 1 CARTON (13533-618-02) / 2 mL in 1 VIAL, GLASS (13533-618-20) | | 1996-08-14 | 0000-00-00 | No | No | Current |
| 13533-618-10 | 13533061810 | 1 VIAL in 1 CARTON (13533-618-10) / 10 mL in 1 VIAL (13533-618-11) | 1 vial | 1996-08-14 | 0000-00-00 | No | No | Current |
| 13533-618-11 | 13533061811 | 10 mL in 1 VIAL | 10 ml | | | | | Historical |
| 13533-618-20 | 13533061820 | 2 mL in 1 VIAL, GLASS | 2 ml | | | | | Historical |